After giving the recommended 1–2 mg/kg/day albumin infusion to a pediatric patient, I have 20 mL of albumin left in the opened glass vial; how should the remaining albumin be stored and must it be discarded if not used within the allowed time?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Storage and Handling of Opened Albumin Vials in Pediatric Patients

According to FDA labeling, partially used albumin vials must be discarded and should not be used if more than 4 hours have elapsed after the container has been entered 1.

Clear FDA Guidance on Opened Vials

The FDA drug label for albumin explicitly states: "Do not begin administration more than 4 hours after the container has been entered. Partially used vials must be discarded" 1. This is a definitive regulatory requirement that supersedes cost considerations.

Key Safety Considerations

  • No preservatives: Albumin (Human) 25% contains no preservative, making it vulnerable to microbial contamination once opened 1
  • Sterility compromise: Once the seal is broken, the sterile barrier is compromised and the risk of contamination increases with time
  • 4-hour window: This is the maximum allowable time from first puncture to completion of administration

Why Storage Is Not Permitted

The prohibition against storing opened albumin vials is based on:

  1. Microbiological safety: Without preservatives, opened vials cannot maintain sterility during storage
  2. Regulatory compliance: The FDA label explicitly forbids use of partially used vials beyond the 4-hour window
  3. Patient safety priority: The risk of bacterial contamination and potential sepsis outweighs cost considerations

Research Context on Vial Reuse

While research on monoclonal antibodies has explored leftover product reuse under specific controlled conditions (showing 0.05% contamination risk with proper needle technique) 2, this does not apply to albumin because:

  • Those studies involved different products with different stability profiles
  • They required specialized aseptic preparation conditions
  • Albumin's FDA label explicitly prohibits this practice

Practical Recommendations

To minimize waste prospectively:

  • Calculate the exact dose needed (1-2 mg/kg/day for pediatrics) before opening vials
  • Order appropriately sized vials when possible to match patient requirements
  • Consider whether the full calculated dose can be given if it requires opening a new vial with significant leftover

Once opened:

  • Use within 4 hours or discard
  • Do not refrigerate or attempt to store for later use
  • Document waste appropriately per institutional protocols

Cost Considerations

While albumin is expensive and the waste is unfortunate, patient safety must take absolute priority over cost. The potential consequences of administering contaminated albumin (sepsis, mortality) far exceed the financial burden of discarded product. The FDA's 4-hour rule and prohibition on reuse of partially used vials exists precisely because the risk-benefit analysis strongly favors disposal.

There is no guideline-supported or FDA-approved method to store opened albumin vials for later use.

References

Research

Use of leftovers of monoclonal antibody products after partial extraction - A microbiological safety study.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020

Related Questions

What are the recommended dosing regimens for 5% and 20% human albumin in adults and pediatric patients?
In an adult with chronic liver disease and no severe cardiac dysfunction or uncontrolled pulmonary edema, how long should 20% human albumin (approximately 1 g/kg, up to 100 g) be infused?
In a patient with chronic liver disease and hypoalbuminemia, what are the indications for albumin infusion and how should the condition be managed?
Is it appropriate to start albumin after the first 24 hours of burn resuscitation, or should it be avoided during the initial phase?
What are the recommended dosing regimens for 5% and 25% albumin infusions in adults and children?
What are the clinical signs of toxic shock syndrome?
What is the maximum safe PEEP level to increase for a patient on mechanical ventilation?
What is the recommended corticosteroid taper regimen for a patient with immunomediated grade 2 nephritis?
For a 50-year-old woman with a positive QuantiFERON‑TB test, should I order a standard posterior‑anterior and lateral chest radiograph (two‑view) or a three‑view chest X‑ray?
What explains the markedly elevated ferritin levels in an adult patient who is malaria-negative, febrile, cytopenic, and being evaluated for hemophagocytic lymphohistiocytosis (HLH)?
In an 18‑month‑old child, which vaccines can be administered now, including diphtheria‑tetanus‑acellular pertussis (DTaP), hepatitis A (Hep A), Haemophilus influenzae type b (Hib), pneumococcal conjugate (PCV13), measles‑mumps‑rubella (MMR), and varicella (VZV)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.